Skip to main content
Livermore
Livermore
ZHEN

Bender Robert & Associates

SEC CIK
0000894300
Latest filing
Jul 30, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Bender Robert & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
2,393
Value
$602.2K
% of portfolio
0.1%
Quarters held
21
Since Q1 2021
Holdings of ABBV by Bender Robert & Associates, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,393$602.2K0.1%00.0%UnchangedHolders
Q1 20262,393$520.5K0.1%−365−13.2%ReducedHolders
Q4 20252,758$630.2K0.1%−224−7.5%ReducedHolders
Q3 20252,982$690.5K0.1%−350−10.5%ReducedHolders
Q2 20253,332$618.5K0.1%−32−1.0%ReducedHolders
Q1 20253,364$704.8K0.2%−933−21.7%ReducedHolders
Q4 20244,297$763.6K0.2%−32−0.7%ReducedHolders
Q3 20244,329$854.9K0.2%+4,329NewHolders
Q2 20240$00.0%−8,524−100.0%Sold outHolders
Q1 20248,524$1.55M0.4%−633−6.9%ReducedHolders
Q4 20239,157$1.42M0.4%−3,727−28.9%ReducedHolders
Q3 202312,884$1.92M0.6%−731−5.4%ReducedHolders
Q2 202313,615$1.83M0.5%−17,349−56.0%ReducedHolders
Q1 202330,964$4.93M1.5%−151−0.5%ReducedHolders
Q4 202231,115$5.03M1.9%−1,176−3.6%ReducedHolders
Q3 202232,291$4.33M1.7%−80−0.2%ReducedHolders
Q2 202232,371$4.96M1.9%−799−2.4%ReducedHolders
Q1 202233,170$5.38M1.5%−1,010−3.0%ReducedHolders
Q4 202134,180$3.69M1.1%00.0%UnchangedHolders
Q3 202134,180$3.69M1.1%−332−1.0%ReducedHolders
Q2 202134,512$3.89M1.1%−150−0.4%ReducedHolders
Q1 202134,662$3.75M1.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.